期刊文献+

稀释曲线法评价TgAb对Tg测定的干扰 被引量:5

TgAb Interference with Experimental Tg Values Detected by Dilution Curves
原文传递
导出
摘要 目的探讨稀释曲线法评价分化型甲状腺癌(DTC)患者内源性甲状腺球蛋白抗体(TgAb)对甲状腺球蛋白(Tg)测定的干扰。方法用血清稀释液、6例DTC患者可测浓度的TgAb血清(TgAb 20~25IU/mL、Tg<0.1μg/L)、5例DTC患者不可测浓度TgAb血清(TgAb<10IU/mL、Tg<0.1μg/L)分别稀释另外6例DTC患者的Tg血清(TgAb<10IU/mL、Tg>10μg/L),三明治夹心法(IMA)测定各稀释管Tg值。以各稀释管Tg理论值为横坐标、实测值为纵坐标,绘制稀释曲线图。结果血清稀释液稀释DTC患者Tg血清,稀释曲线呈直线。6例可测浓度TgAb血清分别稀释6例DTC患者Tg血清,获得36条稀释曲线,其中12条呈直线,24条不呈直线;同一可测浓度TgAb血清稀释不同患者Tg血清,仅部分呈直线;不同患者TgAb血清稀释同一患者Tg血清,仅部分呈直线。5例不可测浓度TgAb血清稀释3例患者Tg血清,只完成稀释曲线11条,仅4条呈直线,7条不呈直线。结论同一患者的TgAb稀释多例患者的Tg血清,部分有干扰。不可测浓度TgAb也可能干扰其他患者的Tg测定。稀释曲线法仅可间接评价DTC患者自身TgAb是否干扰Tg测定。 Objecitve To identify the interference of endogenous antithyroglobulin (TgAb) with experimental thyroglobulin (Tg) values using dilution curves. Methods Dilution buffer, detectable TgAb:serums (TgAb 20-25 IU/mL, Tg free) and undetectable TgAb serums (TgAb 〈10 IU/mL, Tg free) were employed to dilute the Tg serums from patients with DTC, respectively. The Tg values were detected by immunometric assay (IMA). The experimental Tg values (Y-axis) were plotted against expected serum Tg values (X-axis). Diluted curves were used to evaluate the interference of TgAb on the experimental Tg values. A linear dilution curve is supposed to appear if no TgAb interference exists. Results The Tg dilution curves with dilution buffer were linear. Thirty six dilution curves were obtained with TgAb serums from six patients diluted by detectable TgAb serums, and 12 showed linear. Tg serums from six patients diluted by one detectable TgAb serum resulted in both linear and non-linear results. One Tg serum diluted by six TgAb serums also resulted both linear and non-linear results. Tg serums from three patients diluted by five undetectable TgAb serums resulted in 11 dilution curves, four of which were linear. Conclusion Dilution curves can be used to predict TgAb interference indirectly. Detectable TgAb may not interfere with experimental Tg values. Whereas, undetectable TgAb may interfere with Tg values. TgAb could not be used to predict Tg interference.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期432-435,共4页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.30970859)资助
关键词 分化型甲状腺癌 甲状腺球蛋白 甲状腺球蛋白抗体稀 释曲线 Differentiated thyroid cancer Thyroglobulin Antithyroglobulin Dilution curve
  • 相关文献

参考文献9

  • 1Spencer CA. Challenges of serum thyroglobulin ( Tg ) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab,2004;89(8) :3702-3704.
  • 2Cooper DS, Doherty GM, Haugen BR, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009,19(11) :1167-1214.
  • 3Spencer CA, Takeuchi M, Kazarosyan M, et al. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab,1998;83(4) :1121-1127.
  • 4Bachelor A, Cailleux AF, Klain M, et al. Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid, 2002 ; 12 (8) : 707-711.
  • 5Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab,2011 ;96(12): 3615-3627.
  • 6Erali M, Bigelow RB, Meikle AW. ELISA for thyroglobulin in serum., recovery studies to evaluate autoantibody interference and reliability of thyroglobulin values. Clin Chem, 1996 ; 42 ( 5 ) : 766- 770.
  • 7Krahn J, Dembinski T. Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem, 2009; 42 (4- 5) :416-419.
  • 8Algeciras-Schimnich A, Lasho MA, Ness KM, et al. The Roche Elecsys and Siemens-Centaur thyroglobulin autoantibody assays show comparable clinical performance to the recently unavailable Beckman-Coulter access thyroglobulin autoantibody assay in identifying samples with potentially false-low thyroglobulin measurements due to thyroglobulin autoantibody interference. Thyroid, 2011 ; 21 (7) : 813-814.
  • 9Spencer CA, Bergoglio LM, Kazarosyan M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab, 2005; 90 (10) : 556.

同被引文献63

  • 1柴红,陈泽泉,余永利.抗甲状腺球蛋白抗体增高水平及变化趋势对分化型甲状腺癌转移的预测价值[J].中华内分泌代谢杂志,2014,30(4). 被引量:15
  • 2徐立根.ELISA、MAIA、CLIA和TRFIA试剂盒质量标准探讨[J].放射免疫学杂志,2006,19(3):230-234. 被引量:15
  • 3戴庆靖,匡安仁.甲状腺球蛋白测定的临床意义及影响因素[J].同位素,2007,20(2):120-124. 被引量:21
  • 4Spencer CA, Bergoglio LM, Kazarosyan M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas[J]. J Clin Endocrinol Metab, 2005, 90(10): 5566-5575.
  • 5Garas G, Jarral O, Tolley N, et al. Is there survival benefit from life-long follow-up after treatment for differentiated thyroid cancer?[J]. Int J Surg, 2013, 11(2): 116-121.
  • 6Piccardo A, Arecco F, Puntoni M, et al. Focus on High-Risk DTC patients high postoperative serum thyroglobulin level is a strong predictor of disease persistence and is associated to Progression-Free survival and overall survival[J]. Clin Nucl Med, 2013, 38(1): 18-24.
  • 7Rosario PW, Mineiro Filho AF, Prates BS, et al. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive Iodine ablation[J]. Thyroid, 2012, 22(11): 1140-1143.
  • 8Rosario PW, Furtado Mde S, Mineiro Filho AF, et al. Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence[J]. Thyroid, 2012, 22(11): 1165-1169.
  • 9Lim I, Kim SK, Hwang SS, et al. Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the patients with differentiated thyroid cancer[J]. Ann Nucl Med, 2012, 26(10): 777-786.
  • 10Park do J, Lim JA, Kim TH, et al. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation[J]. Endocr J, 2012, 59(11): 1021-1030.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部